6-thio-2'-deoxyguanosine
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 8, 2022 (NCT05208944)
Timeline
Indications
Studied for
Mechanism of action
- Telomerase reverse transcriptaseINHIBITOR
TERT inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06908304 | Phase 3 | Nov 3, 2025 | Maia Biotechnology |
| NCT05208944 | Phase 2 | Jun 8, 2022 | Maia Biotechnology |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Maia Biotechnology | For profit | 2 | 2 | 2 | 2022 |
1 organizations
Page 1 / 1